BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15247044)

  • 1. Senescence marker protein-30 as a novel antiaging molecule.
    Feng D; Kondo Y; Ishigami A; Kuramoto M; Machida T; Maruyama N
    Ann N Y Acad Sci; 2004 Jun; 1019():360-4. PubMed ID: 15247044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver.
    Kondo Y; Ishigami A; Kubo S; Handa S; Gomi K; Hirokawa K; Kajiyama N; Chiba T; Shimokado K; Maruyama N
    FEBS Lett; 2004 Jul; 570(1-3):57-62. PubMed ID: 15251439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMP30 deficiency causes increased oxidative stress in brain.
    Son TG; Zou Y; Jung KJ; Yu BP; Ishigami A; Maruyama N; Lee J
    Mech Ageing Dev; 2006 May; 127(5):451-7. PubMed ID: 16500693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence marker protein-30 knockout mouse as an aging model.
    Maruyama N; Ishigami A; Kuramoto M; Handa S; Kubo S; Imasawa T; Seyama K; Shimosawa T; Kasahara Y
    Ann N Y Acad Sci; 2004 Jun; 1019():383-7. PubMed ID: 15247050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence marker protein-30 (SMP30): structure and biological function.
    Fujita T
    Biochem Biophys Res Commun; 1999 Jan; 254(1):1-4. PubMed ID: 9920722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective roles of senescence marker protein 30 against intracellular calcium elevation and oxidative stress.
    Son TG; Kim SJ; Kim K; Kim MS; Chung HY; Lee J
    Arch Pharm Res; 2008 Jul; 31(7):872-7. PubMed ID: 18704329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence marker protein-30 (SMP30) rescues cell death by enhancing plasma membrane Ca(2+)-pumping activity in Hep G2 cells.
    Fujita T; Inoue H; Kitamura T; Sato N; Shimosawa T; Maruyama N
    Biochem Biophys Res Commun; 1998 Sep; 250(2):374-80. PubMed ID: 9753637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular abnormality in aging: its contribution to clinical pathology].
    Maruyama N; Ishigami A; Kondo Y
    Rinsho Byori; 2005 Aug; 53(8):728-34. PubMed ID: 16190359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and renal expression of senescence marker protein-30 and its biological significance.
    Fujita T; Shirasawa T; Inoue H; Kitamura T; Maruyama N
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S124-31. PubMed ID: 9792046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization of senescence marker protein-30, SMP30, in cultured mouse hepatocytes and its similarity to RNA polymerase.
    Ishigami A; Handa S; Maruyama N; Supakar PC
    Biosci Biotechnol Biochem; 2003 Jan; 67(1):158-60. PubMed ID: 12619687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cells.
    Ishigami A; Fujita T; Inoue H; Handa S; Kubo S; Kondo Y; Maruyama N
    Cell Tissue Res; 2005 May; 320(2):243-9. PubMed ID: 15714273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senescence marker protein-30 knockout mouse as a novel murine model of senile lung.
    Mori T; Ishigami A; Seyama K; Onai R; Kubo S; Shimizu K; Maruyama N; Fukuchi Y
    Pathol Int; 2004 Mar; 54(3):167-73. PubMed ID: 14989739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells.
    Matsuyama S; Kitamura T; Enomoto N; Fujita T; Ishigami A; Handa S; Maruyama N; Zheng D; Ikejima K; Takei Y; Sato N
    Biochem Biophys Res Commun; 2004 Aug; 321(2):386-90. PubMed ID: 15358188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin C deficiency increases the binucleation of hepatocytes in SMP30 knock-out mice.
    Park JK; Hong IH; Ki MR; Chung HY; Ishigami A; Ji AR; Goo MJ; Kim DH; Kwak JH; Min CW; Lee SS; Jeong KS
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1769-76. PubMed ID: 21039840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-associated decrease of senescence marker protein-30/gluconolactonase in individual mouse liver cells: Immunohistochemistry and immunofluorescence.
    Ishigami A; Masutomi H; Handa S; Maruyama N
    Geriatr Gerontol Int; 2015 Jun; 15(6):804-10. PubMed ID: 25311772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of hepatocytes from an Immortomouse/SMP30/GNL knockout mouse hybrid lacking vitamin C to study vitamin C transport.
    Amano A; Handa S; Aigaki T; Shigemoto K; Maruyama N; Ishigami A
    J Biochem; 2011 Dec; 150(6):671-8. PubMed ID: 21903636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological significance of senescence marker protein-30.
    Maruyama N; Ishigami A; Kondo Y
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S88-98. PubMed ID: 20590846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of endogenous regucalcin on protein tyrosine phosphatase activity in the nucleus of rat brain: attenuation with increasing age.
    Tobisawa M; Yamaguchi M
    Int J Mol Med; 2003 Feb; 11(2):205-10. PubMed ID: 12525879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span.
    Ishigami A; Kondo Y; Nanba R; Ohsawa T; Handa S; Kubo S; Akita M; Maruyama N
    Biochem Biophys Res Commun; 2004 Mar; 315(3):575-80. PubMed ID: 14975739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and structure of senescence marker protein-30 (SMP30) and its biological significance.
    Fujita T; Shirasawa T; Maruyama N
    Mech Ageing Dev; 1999 Mar; 107(3):271-80. PubMed ID: 10360682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.